Oil Prices Inch Higher Ahead of Fed Rate Decision and 2025 Outlook

/in /tarafından

Oil prices rose slightly on Wednesday, supported by a notable decline in U.S. crude inventories, although caution prevailed as markets awaited the U.S. Federal Reserve’s decision on interest rates and its 2025 economic projections.

Brent crude futures gained 53 cents (0.7%) to trade at $73.72 per barrel, while U.S. West Texas Intermediate (WTI) crude increased 54 cents (0.8%) to reach $70.62 per barrel at 1436 GMT.

Market Focus: Fed Rate Decision

The Federal Reserve is widely expected to announce a quarter-point rate cut, signaling a gradual loosening of monetary policy. However, investors are more focused on potential indications of a pause in January and the extent of rate cuts projected for 2025, according to Charalampos Pissouros, senior investment analyst at XM.

The central bank will release its policy statement at 2 p.m. ET (1900 GMT), followed by comments from Chair Jerome Powell. Lower interest rates generally reduce borrowing costs, which can stimulate economic growth and, consequently, drive up oil demand.

Crude Inventory Trends

Adding to market optimism, data from the American Petroleum Institute (API) revealed that U.S. crude stocks dropped by 4.69 million barrels in the week ending December 13. However, gasoline inventories rose by 2.45 million barrels, and distillate stocks increased by 744,000 barrels, according to the same report.

Analysts polled by Reuters had anticipated a smaller draw of 1.6 million barrels during the week, suggesting a tighter crude supply environment than expected. The U.S. Energy Information Administration (EIA) is set to release its official inventory data later on Wednesday, which could further influence price movements.

Oil Market Sentiment

John Evans, an analyst at oil brokerage PVM, noted that the crude inventory draw could have sparked a stronger market reaction. However, the ongoing focus on central bank decisions has led to cautious trading across various markets.

“Investors are taking a light touch approach, given the diverting power of central bank rate decisions,” Evans explained.

Meanwhile, UBS analyst Giovanni Staunovo pointed to lingering uncertainties, including trade tensions and speculation on how aggressively the Fed will cut rates in 2025, as factors capping the upside potential for oil prices.

Broader Market Implications

If the Fed signals a measured pace of rate cuts, oil prices could find sustained support as lower borrowing costs typically foster economic activity and energy consumption. Still, concerns over a weaker global demand outlook and geopolitical risks continue to weigh on the market’s longer-term prospects.

 

OPEC+ Concerned About Rising U.S. Oil Output Under Trump’s Leadership

/in /tarafından

OPEC+ is expressing concerns about a potential surge in U.S. oil production if Donald Trump returns to the White House, delegates from the group said. Increased U.S. output could further erode OPEC+’s market share and hinder its ability to maintain high oil prices, a priority for the producer alliance.

OPEC+ Strategy at Risk

Currently, OPEC+—which accounts for roughly 50% of global oil supply—has delayed plans to raise production until April and extended some supply cuts until the end of 2026 due to weak demand and growing output from non-OPEC+ producers, particularly the U.S. Over the past decade, the U.S. has become the world’s largest oil producer, now accounting for 20% of global oil supply.

The renewed concern comes as Trump’s transition team is reportedly preparing a wide-ranging energy deregulation package, promising a boost to U.S. oil production. While OPEC+ acknowledges that less stringent environmental policies under Trump could be favorable for the global oil industry, the expected rise in American output is seen as a challenge.

One delegate from an OPEC+ member aligned with the U.S. commented, “Trump’s return could be good for the oil industry, but higher U.S. production is not good for us.”

U.S. Oil Output Trends

OPEC’s data indicates that U.S. oil output has risen by 11% between 2022 and 2024, reaching 21.6 million barrels per day (bpd). This surge in production has contributed to OPEC+’s declining market share, which now stands at 48% of global supply, down from over 55% in 2016 when the alliance was formed.

OPEC+ has faced challenges maintaining its influence, especially as U.S. shale oil output has flourished. Decisions to reduce production in 2016 and 2020 inadvertently supported the growth of the U.S. shale industry, turning it into a leading global exporter.

Looking ahead, OPEC+ plans to ease production cuts starting in April 2025. However, any significant rise in U.S. output could risk a drop in oil prices, harming OPEC+ nations heavily reliant on oil revenues.

Industry Dynamics Under Trump

Trump campaigned on promises to lower energy costs and inflation, goals that align with boosting domestic oil production. According to Richard Bronze, head of geopolitics at Energy Aspects, “This is a potentially difficult dynamic for both sides. Rising U.S. production has reduced OPEC+’s influence on the market.”

Still, some industry analysts doubt that Trump’s policies alone could lead to a substantial near-term increase in U.S. output. Shale producers remain focused on profitability, known as capital discipline, and are unlikely to expand production without favorable prices. Moreover, new oilfields take years to develop, meaning Trump’s promises to expedite drilling permits may not immediately translate into higher output.

Bob McNally, president of Rapidan Energy Group, explained, “The U.S. has no spare capacity. How much the U.S. will drill depends more on decisions made in Vienna than in Washington.”

OPEC’s Outlook and Challenges

OPEC’s latest report forecasts U.S. oil supply to grow by 2.3% in 2024, while the International Energy Agency (IEA) predicts a faster growth rate of 3.5%. At the same time, OPEC has lowered its global demand growth forecast, reflecting uncertainties in the market.

Despite these challenges, some OPEC+ delegates see a potential silver lining. A source noted that while rising U.S. production poses risks, Trump’s policies could also boost global oil demand, indirectly benefiting the producer group.

As OPEC+ prepares for a future where U.S. shale continues to expand its market share, the group faces a delicate balance of managing production cuts and maintaining price stability.

 

Nestle Introduces Protein Shots to Target Weight-Loss Drug Users in the U.S.

/in /tarafından

Nestle (NESN.S), the world’s largest food company, has launched a new product in the United States aimed at weight-loss drug users: Boost Pre-Meal Hunger Support, a protein shot designed to suppress appetite. This move marks another step in the company’s strategy to capitalize on the growing demand for weight-loss solutions.

About the Product

The Boost Pre-Meal Hunger Support shots are intended to be consumed 30 minutes before a meal. Nestle claims the drink promotes a natural GLP-1 hormone response, mimicking but on a smaller scale the appetite-suppressing effects of weight-loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. These popular medications, administered via weekly injections, are known for reducing hunger and inducing feelings of fullness.

Priced at $10.99 for a pack of four, the shots contain:

  • 10 grams of whey protein
  • 45 calories
  • 1 gram of sugar
  • Zero fat

The shots are currently available on Amazon.com and in select CVS stores.

Mechanism and Claims

Nestle’s Chief Technology Officer, Stefan Palzer, explains that the protein shot’s formula includes a patented mix of peptides designed to trigger a natural GLP-1 response in the body. The product is based on whey protein micro-gels, which digest more slowly and interact longer with intestinal receptors to release the GLP-1 hormone.

This is not intended to replace weight-loss drugs but may complement their effects or help individuals maintain weight loss, Palzer said. Nestle has also patented the product’s formula to protect its unique mix of peptides and micro-gel technology.

The Science Behind It

Nestle conducted a study in 2021 involving 26 participants with type-2 diabetes, comparing the effects of whey protein microgel against a placebo. Results showed:

  • 22% reduction in glucose levels two hours after a meal in the whey protein group.
  • A positive effect on GLP-1 hormone levels.

While these findings suggest potential benefits, experts remain cautious. Dr. Lora Heisler, a nutrition researcher at the Rowett Institute, stated that while the product may boost GLP-1 levels, the effects might be comparable to consuming a glass of milk, questioning its long-term impact on weight loss.

Nestle’s Broader Strategy

The protein shots are part of a broader push by Nestle to cater to the booming obesity treatment market, which analysts project could reach $150 billion annually within a decade. Earlier this year, the company introduced protein-enriched frozen pizzas and pastas in the U.S., designed for people taking weight-loss drugs.

Nestle’s move comes amid significant shifts in consumer habits driven by the increasing popularity of weight-loss medications. In 2022, Walmart reported a slight decline in food consumption among customers using these drugs, triggering a market-wide selloff in food company shares, including Nestle’s.

Appetite for Weight-Loss Products

Nestle’s new product seeks to tap into the growing market for alternatives to injectables. While the shots offer a less powerful solution compared to medications like Wegovy or Zepbound, they provide a convenient, non-prescription option for individuals looking to manage their weight.

The protein shots also highlight Nestle’s ambition to innovate within the weight-loss segment, focusing on products that align with shifting consumer needs and health trends.